Postoperative concurrent radiochemotherapy versus radiotherapy in high-risk SCCA of the head and neck: Results of the German phase III trial ARO 96-3.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Clinical Oncology

• Publication date

  2006-06-20

• Fields of study

  Medicine

• Identifiers
  DOI 10.1200/JCO.2006.24.18_SUPPL.5507PMID 27954562
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Current status and future perspective of postoperative treatment for locally advanced squamous cell carcinoma of the head and neck

  2024cites this paper
• De-intensification of postoperative radiotherapy in head and neck cancer irrespective of human papillomavirus status—results of a prospective multicenter phase II trial (DIREKHT Trial)

  2024cites this paper
• Improved survival of locoregional-advanced larynx and hypopharynx cancer patients treated according to the DeLOS-II protocol

  2024cites this paper
• The role of the genomic mutation signature and tumor mutation burden on relapse risk prediction in head and neck squamous cell carcinoma after concurrent chemoradiotherapy

  2023cites this paper
• Postoperative adjuvant radiochemotherapy with cisplatin versus adjuvant radiochemotherapy with cisplatin and pembrolizumab in locally advanced head and neck squamous cell carcinoma- the study protocol of the Adrisk trial

  2023cites this paper
• [Postoperative radiotherapy with cetuximab for head and neck squamous cell carcinoma patients at high risk of recurrence not eligible for cisplatin: A single-center experience and literature review].

  2022cites this paper
• Current Indications for Intraarterial Chemotherapy in Neurointerventional Surgery

  2022cites this paper
• Dose Reduction to the Swallowing Apparatus and the Salivary Glands by De-Intensification of Postoperative Radiotherapy in Patients with Head and Neck Cancer: First (Treatment Planning) Results of the Prospective Multicenter DIREKHT Trial

  2020cites this paper
• ERKRANKUNGEN DES BLUTES UND DES GERINNUNGSSYSTEMS, SOLIDE TUMOREN UND PRINZIPIEN DER INTERNISTISCHEN ONKOLOGIE

  2020cites this paper
• Postoperative radiotherapy is associated with improved overall survival for alveolar ridge squamous cell carcinoma with adverse pathologic features

  2020cites this paper
• Is there a patient population with squamous cell carcinoma of the head and neck region who might benefit from de-intensification of postoperative radiotherapy?

  2019cites this paper
• Behandlungsstrategien beim Oropharynxkarzinom

  2019cites this paper
• SDF-1 / CXCR 4 as prognostic markers for postoperative radiochemotherapy in head and neck cancer

  2018cites this paper
• Aktueller Status der Therapie und Prophylaxe des Oropharynxkarzinoms

  2018cites this paper
• Development and Validation of a Gene Signature for Patients with Head and Neck Carcinomas Treated by Postoperative Radio(chemo)therapy

  2018cites this paper
• Patterns of care analysis for head & neck cancer of unknown primary site: a survey inside the German society of radiation oncology (DEGRO)

  2018cites this paper
• Postoperative (chemo) radiation in patients with squamous cell cancers of the head and neck – clinical results from the cohort of the clinical cooperation group “Personalized Radiotherapy in Head and Neck Cancer”

  2018cites this paper
• Patient and Treatment Factors in Concurrent Chemoradiotherapy

  2017cites this paper
• Phase I Study of Definitive Radio-chemotherapy with Cisplatin, 5-Fluorouracil and Cetuximab for Unresectable Locally Advanced Esophageal Cancer.

  2017cites this paper
• The Role of Radiotherapy in the Definitive and Postoperative Treatment of Advanced Head and Neck Cancer

  2017cites this paper
• Development and validation of a gene signature for patients with head and 1 neck carcinomas treated by postoperative radio(chemo)therapy

  2017cites this paper
• SDF-1/CXCR4 expression in head and neck cancer and outcome after postoperative radiochemotherapy

  2017cites this paper
• Low Cancer Stem Cell Marker Expression and Low Hypoxia Identify Good Prognosis Subgroups in HPV(−) HNSCC after Postoperative Radiochemotherapy: A Multicenter Study of the DKTK-ROG

  2016cites this paper
• Independent validation of the prognostic value of cancer stem cell marker expression and hypoxia-induced gene expression for patients with locally advanced HNSCC after postoperative radiotherapy

  2016cites this paper
• Chemoradiation of locally advanced squamous cell carcinoma of the head-and-neck (LASCCHN): Is 20mg/m(2) cisplatin on five days every four weeks an alternative to 100mg/m(2) cisplatin every three weeks?

  2016cites this paper
• Improved overall survival and mortality in head and neck cancer with adjuvant concurrent chemoradiotherapy in national databases

  2016cites this paper
• Do we need 5-FU in addition to cisplatin for chemoradiation of locally advanced head-and-neck cancer?

  2016cites this paper
• Radiochemotherapy for locally advanced squamous cell carcinoma of the head and neck: Higher-dose cisplatin every 3 weeks versus cisplatin/5-fluorouracil every 4 weeks.

  2016cites this paper
• High‐grade histology as predictor of early distant metastases and decreased disease‐free survival in salivary gland cancer irrespective of tumor subtype

  2016cites this paper
• Oral Cavity Cancer

  2016cites this paper
• Prolonged radiation time and low nadir hemoglobin during postoperative concurrent chemoradiotherapy are both poor prognostic factors with synergistic effect on locally advanced head and neck cancer patients

  2015cites this paper
• Refusal of postoperative radiotherapy and its association with survival in head and neck cancer.

  2015cites this paper
• Impact of indication-shift of primary and adjuvant chemo radiation in advanced laryngeal and hypopharyngeal squamous cell carcinoma

  2015cites this paper
• Adjuvant treatment for post-operative head and neck squamous cell carcinoma.

  2015cites this paper
• [The primary use of pectoralis myofascial flap in salvage laryngectomy].

  2014cites this paper
• Quality assurance for the EORTC 22071–26071 study: dummy run prospective analysis

  2014cites this paper
• HPV in

  2014cites this paper
• Die Behandlung chronischer Wunden im Kopf-Hals-Bereich nach Radiatio mit medizinischem Honig

  2014cites this paper
• HPV16 DNA status is a strong prognosticator of loco-regional control after postoperative radiochemotherapy of locally advanced oropharyngeal carcinoma: results from a multicentre explorative study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).

  2014cites this paper
• Chirurgisches Management der persistierenden Speichelfistel nach Salvage-Laryngektomie

  2013cites this paper
• Feasibility of 6-month maintenance cetuximab after adjuvant concurrent chemoradiation plus cetuximab in squamous cell carcinoma of the head and neck

  2013cites this paper
• Impact of Postoperative Radiotherapy and Chemotherapy on Survival for Patients with Node Positive Oral Cancer

  2013influential citation
• Chirurgisches Management der persistierenden Speichelfistel nach Salvage-Laryngektomie

  2013cites this paper
• A Phase II Study of the Role of Selective Cyclo oxygen ase-2 ( COX-2 ) Inhibitor and Concurrent Chemoradiation as Adjuvant Postoperative Treatment in Patients with Locally Advanced Cancer

  2013cites this paper
• Postoperative treatment of head and neck cancer based on EBM

  2013cites this paper
• Postoperative radiochemotherapy with weekly cisplatin in patients with head and neck cancer single-institution outcome analysis.

  2012cites this paper
• Zervikales CUP-Syndrom

  2012cites this paper
• Simultane Radiochemotherapie zur Behandlung solider Tumoren

  2012cites this paper
• ERCC1 protein, mRNA expression and T19007C polymorphism as prognostic markers in head and neck squamous cell carcinoma patients treated with surgery and adjuvant cisplatin-based chemoradiation.

  2011cites this paper
• Carcinoma del cavo orale

  2011cites this paper
• Adjuvant Low Single Dose Cisplatin-based Concurrent Radiochemotherapy of Oral Cavity and Oropharynx Carcinoma

  2011influential citation
• ACR appropriateness criteria® adjuvant therapy for resected squamous cell carcinoma of the head and neck.

  2011cites this paper
• Prognostic markers in head and neck cancer

  2011influential citation
• ADJUVANT THERAPY FOR RESECTED SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK

  2011cites this paper
• Postoperative Therapy in Head and Neck Cancer: State of the Art, Risk Subset, Prognosis and Unsolved Questions

  2011cites this paper
• Radiation Therapy for Cancer of the Larynx and Hypopharynx

  2010cites this paper
• RADIATION THERAPY ONCOLOGY GROUP RTOG 0619 A RANDOMIZED PHASE II TRIAL OF CHEMORADIOTHERAPY VERSUS CHEMORADIOTHERAPY AND VANDETANIB FOR HIGH-RISK POSTOPERATIVE ADVANCED SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK

  2010cites this paper
• Supportive care in head and neck oncology

  2010cites this paper
• Ergebnisse und Nebenwirkungen bei kom- binierter adjuvanter Radiochemotherapie von Tumoren im Kopf-Hals-Bereich

  2009cites this paper
• Expressão da proteína ERCC1 (Excision Repair Cross Complementing Group 1), do seu RNA mensageiro e de polimorfismos genéticos como fatores prognósticos em pacientes portadores de carcinoma epidermóide de cabeça e pescoço operados e submetidos à quimiorradioterapia adjuvante

  2009cites this paper
• The Contribution of Chemotherapy

  2009cites this paper
• Distribution of immune cells in head and neck cancer: CD8+ T-cells and CD20+ B-cells in metastatic lymph nodes are associated with favourable outcome in patients with oro- and hypopharyngeal carcinoma

  2009cites this paper
• Strahlen-, Chemo- und Targettherapie von Kopf-Hals-Karzinomen

  2009cites this paper
• Long‐Term Results of a Phase III Randomized Trial of Postoperative Radiotherapy With or Without Carboplatin in Patients With High‐Risk Head and Neck Cancer

  2008cites this paper
• Expanding Role of the Medical Oncologist in the Management of Head and Neck Cancer

  2008cites this paper
• Kopf-Hals-Karzinome

  2008cites this paper
• Adjuvante Behandlung von Tumoren der Kopf-Hals-Region

  2007influential citation
• Chemoradiotherapy for locally advanced head and neck cancer.

  2007cites this paper
• Chemo-enhanced radiotherapy in squamous cell carcinoma – Is there evidence for different regimes?

  2007cites this paper
• Selected topics in head and neck cancer

  2006cites this paper
• Current opinion in diagnosis and treatment of laryngeal carcinoma.

  2006cites this paper